Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for BRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -77.40M
March 31, 2026 71.20M
December 31, 2025 229.80M
September 30, 2025 -33.20M
June 30, 2025 -127.50M
March 31, 2025 65.00M
December 31, 2024 190.00M
September 30, 2024 38.40M
June 30, 2024 1.10M
March 31, 2024 21.80M
December 31, 2023 205.50M
September 30, 2023 44.10M
June 30, 2023 13.00M
March 31, 2023 87.50M
December 31, 2022 171.50M
September 30, 2022 69.50M
June 30, 2022 -44.40M
March 31, 2022 77.80M
December 31, 2021 138.60M
September 30, 2021 23.90M
June 30, 2021 21.90M
March 31, 2021 98.00M
December 31, 2020 203.00M
September 30, 2020 82.40M
June 30, 2020 11.80M
Date Value
March 31, 2020 35.00M
December 31, 2019 136.20M
September 30, 2019 52.40M
June 30, 2019 10.60M
March 31, 2019 14.20M
December 31, 2018 132.30M
September 30, 2018 27.50M
June 30, 2018 36.10M
March 31, 2018 43.80M
December 31, 2017 103.70M
September 30, 2017 35.30M
June 30, 2017 -17.20M
March 31, 2017 32.60M
December 31, 2016 90.80M
September 30, 2016 35.90M
June 30, 2016 18.10M
March 31, 2016 -14.00M
December 31, 2015 149.60M
September 30, 2015 54.10M
June 30, 2015 -1.50M
March 31, 2015 27.00M
December 31, 2014 69.30M
September 30, 2014 13.50M
June 30, 2014 13.00M
March 31, 2014 18.50M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 2.125B
Agilent Technologies, Inc. 519.00M
Bio-Rad Laboratories, Inc. 98.70M
Danaher Corp. 1.534B
Illumina, Inc. 201.00M